The long-term goal of this proposal is to understand specific molecular mechanisms of Tgf-beta signaling that take place during palatal fusion. This is very important since failure of these processes has been shown to lead to cleft palate, one of the most common birth defects in humans. Others and we have previously shown that during palatal fusion transforming growth factor-betas (Tgf-betas) induce several downstream responses that contribute to the successful palatogenesis. This proposal focuses on the role of epithelial and mesenchymal Tgf-beta signals in coordination of palatal fusion. Our overall hypothesis is: Tgf-beta/Bmp signaling events both in the palatal mesenchyme and in the epithelium are critical for successful palatal fusion and play a concerted role during palatogenesis. We propose to test this hypothesis by five Specific Aims.
In Aim 1 we propose to determine the effect of neural crest cell specific abrogation of the Tgf-b type I receptor AIk2 on palatal development.
In Aim 2, we propose to define the role of Tgf-beta type I receptors AIk2 and AIk5 in the palatal midline epithelium during palatal fusion, in Aim 3 we propose to determine the role of reciprocal epithelio-mesenchymal Tgf-beta signaling during palatal fusion, in Aim 4 we propose to analyze why direct contact between the palatal epithelium and mesenchyme can bypass the Tgf-beta3 signaling defect, and finally in Aim 5 we propose to determine the role of gap junctions in Tgf-beta-induced palatal midline epithelial fusion. Our unique experimental models and the state-of-art strategy allow us to determine the role Tgf-beta signaling via AIk5 and AIk2 in palatogenesis. Collectively, the proposed experiments are likely to be of critical importance in attempting to understand the molecular bases of facial and palatal cleftings in humans, and to develop possible therapeutic approaches to treat cleft palate during the fetal period.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
Research Project (R01)
Project #
Application #
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Scholnick, Steven
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital of Los Angeles
Los Angeles
United States
Zip Code
Pan, Haichun; Zhang, Honghao; Abraham, Ponnu et al. (2017) BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development. Dev Biol 429:260-270
Rajderkar, Sudha; Panaretos, Christopher; Kaartinen, Vesa (2017) Trim33 regulates early maturation of mouse embryoid bodies in vitro. Biochem Biophys Rep 12:185-192
Lane, Jamie; Yumoto, Kenji; Azhar, Mohamad et al. (2015) Tak1, Smad4 and Trim33 redundantly mediate TGF-?3 signaling during palate development. Dev Biol 398:231-41
Agarwal, Shailesh; Loder, Shawn J; Brownley, Cameron et al. (2015) BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints. Dev Biol 400:202-9
Zhang, Honghao; Takeda, Haruko; Tsuji, Takehito et al. (2015) Generation of Evc2/Limbin global and conditional KO mice and its roles during mineralized tissue formation. Genesis 53:612-626
Lane, Jamie; Kaartinen, Vesa (2014) Signaling networks in palate development. Wiley Interdiscip Rev Syst Biol Med 6:271-8
Gay, Leslie; Karfilis, Kate V; Miller, Michael R et al. (2014) Applying thiouracil tagging to mouse transcriptome analysis. Nat Protoc 9:410-20
Lane, Jamie; Yumoto, Kenji; Pisano, Justin et al. (2014) Control elements targeting Tgfb3 expression to the palatal epithelium are located intergenically and in introns of the upstream Ift43 gene. Front Physiol 5:258
Bogenmann, Emil; Thomas, Penny S; Li, Qianfeng et al. (2011) Generation of mice with a conditional allele for the p75(NTR) neurotrophin receptor gene. Genesis 49:862-9
Kamiya, Nobuhiro; Kaartinen, Vesa M; Mishina, Yuji (2011) Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1. Biochem Biophys Res Commun 414:326-30

Showing the most recent 10 out of 34 publications